Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus versus continuous nitroglycerin infusion in acute hypertensive heart failure
PACTR201905684437789Phase 3Recruiting
- Sponsor
- Benha University
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of nitroglycerin in Acute Heart Failure (AHF) and hypertensive emergency, sponsored by Benha University. Primary endpoint: Primary endpoint not reported. Started Oct 2018; status: recruiting.
02
Drugs
nitroglycerin
03
Conditions
Acute Heart Failure (AHF)hypertensive emergency
Beyond the preview
Go deeper on PACTR201905684437789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201905684437789.